Hoogerbrugge N - Search Results

1

Breast cancer size estimation with MRI in BRCA mutation carriers and other high risk patients.

Mann RM, Bult P, van Laarhoven HW, Span PN, Schlooz M, Veltman J, Hoogerbrugge N. Mann RM, et al. Among authors: hoogerbrugge n. Eur J Radiol. 2013 Sep;82(9):1416-22. doi: 10.1016/j.ejrad.2013.03.003. Epub 2013 Apr 6. Eur J Radiol. 2013. PMID: 23567481

2

High prevalence of premalignant lesions in prophylactically removed breasts from women at hereditary risk for breast cancer.

Hoogerbrugge N, Bult P, de Widt-Levert LM, Beex LV, Kiemeney LA, Ligtenberg MJ, Massuger LF, Boetes C, Manders P, Brunner HG. Hoogerbrugge N, et al. J Clin Oncol. 2003 Jan 1;21(1):41-5. doi: 10.1200/JCO.2003.02.137. J Clin Oncol. 2003. PMID: 12506168 Free article.

3

Randomized trial of a shared decision-making intervention consisting of trade-offs and individualized treatment information for BRCA1/2 mutation carriers.

van Roosmalen MS, Stalmeier PF, Verhoef LC, Hoekstra-Weebers JE, Oosterwijk JC, Hoogerbrugge N, Moog U, van Daal WA. van Roosmalen MS, et al. Among authors: hoogerbrugge n. J Clin Oncol. 2004 Aug 15;22(16):3293-301. doi: 10.1200/JCO.2004.05.066. J Clin Oncol. 2004. PMID: 15310772 Free article. Clinical Trial.

4

[In cases of familial ovarian cancer, always consider the risk of breast cancer].

Kets CM, Niermeijer MF, Massuger LF, Hoogerbrugge N. Kets CM, et al. Among authors: hoogerbrugge n. Ned Tijdschr Geneeskd. 2004 Aug 28;148(35):1709-11. Ned Tijdschr Geneeskd. 2004. PMID: 15468897 Dutch.

5

Genetic uptake in BRCA-mutation families is related to emotional and behavioral communication characteristics of index patients.

Landsbergen K, Verhaak C, Kraaimaat F, Hoogerbrugge N. Landsbergen K, et al. Among authors: hoogerbrugge n. Fam Cancer. 2005;4(2):115-9. doi: 10.1007/s10689-004-7991-2. Fam Cancer. 2005. PMID: 15951961

6

Surveillance of women at high risk for hereditary ovarian cancer is inefficient.

Oei AL, Massuger LF, Bulten J, Ligtenberg MJ, Hoogerbrugge N, de Hullu JA. Oei AL, et al. Among authors: hoogerbrugge n. Br J Cancer. 2006 Mar 27;94(6):814-9. doi: 10.1038/sj.bjc.6603015. Br J Cancer. 2006. PMID: 16495917 Free PMC article.

7

Numerous high-risk epithelial lesions in familial breast cancer.

Hoogerbrugge N, Bult P, Bonenkamp JJ, Ligtenberg MJ, Kiemeney LA, de Hullu JA, Boetes C, Niermeijer MF, Brunner HG. Hoogerbrugge N, et al. Eur J Cancer. 2006 Oct;42(15):2492-8. doi: 10.1016/j.ejca.2006.05.027. Eur J Cancer. 2006. PMID: 16908132

8

Optimal selection for BRCA1 and BRCA2 mutation testing using a combination of 'easy to apply' probability models.

Bodmer D, Ligtenberg MJ, van der Hout AH, Gloudemans S, Ansink K, Oosterwijk JC, Hoogerbrugge N. Bodmer D, et al. Among authors: hoogerbrugge n. Br J Cancer. 2006 Sep 18;95(6):757-62. doi: 10.1038/sj.bjc.6603306. Epub 2006 Aug 15. Br J Cancer. 2006. PMID: 16909138 Free PMC article.

9

The impact of a false-positive MRI on the choice for mastectomy in BRCA mutation carriers is limited.

Hoogerbrugge N, Kamm YJ, Bult P, Landsbergen KM, Bongers EM, Brunner HG, Bonenkamp HJ, de Hullu JA, Ligtenberg MJ, Boetes C. Hoogerbrugge N, et al. Ann Oncol. 2008 Apr;19(4):655-9. doi: 10.1093/annonc/mdm537. Epub 2007 Dec 19. Ann Oncol. 2008. PMID: 18096566 Free article.

10

Breast tumor characteristics of BRCA1 and BRCA2 gene mutation carriers on MRI.

Veltman J, Mann R, Kok T, Obdeijn IM, Hoogerbrugge N, Blickman JG, Boetes C. Veltman J, et al. Among authors: hoogerbrugge n. Eur Radiol. 2008 May;18(5):931-8. doi: 10.1007/s00330-008-0851-y. Epub 2008 Feb 13. Eur Radiol. 2008. PMID: 18270717 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

336 results

Search Page